William N. (Bill) Anderson


Personal Data

Nationality: American
Year of Birth: 1966


CEO Roche Pharmaceuticals


  • Massachusetts Institute of Technology, M.Sc. in Management; M.Sc.in Chemical Engineering
  • University of Texas, Austin, B. S. in Chemical Engineering

Professional Career

  • 1989
    Process Engineer, R&D, Ethyl Corporation, The Hague, Netherlands
  • 1990
    Engineer/Shift Supervisor, Ethyl Corporation, Brussels, Belgium
  • 1995
    Business Development/Marketing Manager, Raychem Corporation, SF Bay Area, USA
  • 1997
    Business Planning Manager, Biogen, Cambridge, Massachusetts, USA
  • 1999
    Managing Director, United Kingdom and Ireland, Biogen, London, UK
  • 2001
    Vice President of Finance, Business Planning, Biogen Idec., Cambridge, Massachusetts, USA
  • 2004
    Vice President and General Manager, Neurology Business Unit, Biogen Idec., USA
  • 2006
    Senior Vice President, Immunology and Ophthalmology Business Unit, Genentech, USA
  • 2010
    Senior Vice President, BioOncology Business Unit, Genentech, USA
  • 2013
    Global Product Strategy Head/Chief Marketing Officer, Roche Pharmaceuticals, Basel, Switzerland
  • 2016
    Head of North American Operations, Genentech, USA
  • 2017-2018
    Chief Executive Officer, Genentech, USA
  • 2019-present
    CEO Roche Pharmaceutical

Board Memberships in listed companies

  • 2019-present
    Chugai Pharmaceuticals

Other Activities / Memberships

  • FHI (Flatiron Health, Inc.)
  • FMI (Foundation Medicine, Inc.)
  • GNE (Genentech, Inc.)
  • Spark Therapeutics
  • 2017-2018
    BIO (Biotechnology Innovation Organization)
  • 2019-2020
    PhRMA (Pharmaceutical Research and Manufacturers of America)
  • Jan 2021-present
    European Federation of Pharmaceuticals Industries and Associations